10 20 30 40 50 60 70 80 1GL4 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER BASEMENT MEMBRANE 23-AUG-01 1GL4
TITLE NIDOGEN-1 G2/PERLECAN IG3 COMPLEX
COMPND MOL_ID: 1; COMPND 2 MOLECULE: NIDOGEN-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: G2 RESIDUES 385-665; COMPND 5 SYNONYM: ENTACTIN; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: BASEMENT MEMBRANE-SPECIFIC HEPARAN SULFATE COMPND 9 PROTEOGLYCAN CORE PROTEIN; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: IG3 RESIDUES 1765-1858; COMPND 12 SYNONYM: PERLECAN, HSPG, PLC; COMPND 13 ENGINEERED: YES; COMPND 14 OTHER_DETAILS: VECTOR-DERIVED N-TERMINAL APLA
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: 293-EBNA; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PCEP-PU; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 11 ORGANISM_COMMON: MOUSE; SOURCE 12 ORGANISM_TAXID: 10090; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 15 EXPRESSION_SYSTEM_CELL_LINE: 293-EBNA; SOURCE 16 EXPRESSION_SYSTEM_VECTOR: PCEP-PU; SOURCE 17 OTHER_DETAILS: VECTOR-DERIVED N-TERMINAL APLA
KEYWDS BASEMENT MEMBRANE, IMMUNOGLOBULIN-LIKE DOMAIN, KEYWDS 2 EXTRACELLULAR MATRIX, PROTEOGLYCAN, HEPARAN SULFATE
EXPDTA X-RAY DIFFRACTION
AUTHOR M.KVANSAKUL,M.HOPF,A.RIES,R.TIMPL,E.HOHENESTER
REVDAT 2 24-FEB-09 1GL4 1 VERSN REVDAT 1 28-NOV-01 1GL4 0
JRNL AUTH M.KVANSAKUL,M.HOPF,A.RIES,R.TIMPL,E.HOHENESTER JRNL TITL STRUCTURAL BASIS FOR THE HIGH-AFFINITY INTERACTION JRNL TITL 2 OF NIDOGEN-1 WITH IMMUNOGLOBULIN-LIKE DOMAIN 3 OF JRNL TITL 3 PERLECAN JRNL REF EMBO J. V. 20 5342 2001 JRNL REFN ISSN 0261-4189 JRNL PMID 11574465 JRNL DOI 10.1093/EMBOJ/20.19.5342
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.HOPF,W.GOHRING,A.RIES,R.TIMPL,E.HOHENESTER REMARK 1 TITL CRYSTAL STRUCTURE AND MUTATIONAL ANALYSIS OF A REMARK 1 TITL 2 PERLECAN-BINDING FRAGMENT OF NIDOGEN-1 REMARK 1 REF NAT.STRUCT.BIOL . V. 8 634 2001 REMARK 1 REFN ISSN 1072-8368 REMARK 1 PMID 11427896 REMARK 1 DOI 10.1038/89683 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.HOPF,W.GOHRING,K.MANN,R.TIMPL REMARK 1 TITL MAPPING OF BINDING SITES FOR NIDOGENS, FIBULIN-2, REMARK 1 TITL 2 FIBRONECTIN AND HEPARIN TO DIFFERENT IG MODULES OF REMARK 1 TITL 3 PERLECAN REMARK 1 REF J.MOL.BIOL. V. 311 529 2001 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 11493006 REMARK 1 DOI 10.1006/JMBI.2001.4878
REMARK 2 REMARK 2 RESOLUTION. 2.0 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.0 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 29096 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.0 REMARK 3 FREE R VALUE TEST SET COUNT : 2898 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.01 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 511 REMARK 3 BIN R VALUE (WORKING SET) : 0.228 REMARK 3 BIN FREE R VALUE : 0.234 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.0 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 59 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2803 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 16 REMARK 3 SOLVENT ATOMS : 174 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.3 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.288 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : INDIVIDUAL RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.358 ; 1.5 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.072 ; 2.0 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.194 ; 2.0 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.193 ; 2.5 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : CIS_PEPTIDE.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1GL4 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-AUG-01. REMARK 100 THE PDBE ID CODE IS EBI-8482.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-NOV-00 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX9.6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : QUANTUM4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29096 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.08900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.25600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1H4U REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.1 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG 6000, REMARK 280 5% MPD, 0.1 M HEPES PH 7.5
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.96000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.96500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.15000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.96500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.96000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.15000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 353 REMARK 465 PRO A 354 REMARK 465 LEU A 355 REMARK 465 ALA A 356 REMARK 465 GLN A 357 REMARK 465 GLN A 358 REMARK 465 ASP A 632 REMARK 465 GLY A 633 REMARK 465 SER A 634 REMARK 465 PRO A 635 REMARK 465 ASP A 636 REMARK 465 ALA A 637 REMARK 465 ALA B 1761 REMARK 465 PRO B 1762 REMARK 465 LEU B 1763 REMARK 465 ALA B 1764 REMARK 465 ALA B 1765 REMARK 465 PRO B 1766 REMARK 465 SER B 1767 REMARK 465 LYS B 1768 REMARK 465 VAL B 1858
REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; REMARK 480 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 480 I=INSERTION CODE): REMARK 480 M RES CSSEQI ATOMS REMARK 480 ARG B1783 CB CG CD NE CZ NH1 NH2
REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 445 58.20 98.22 REMARK 500 LEU A 457 46.24 -82.48 REMARK 500 SER A 547 115.46 -166.43 REMARK 500 ASP A 565 78.50 -69.77 REMARK 500 HIS A 590 -165.25 -117.89 REMARK 500 ASP A 591 68.03 63.40 REMARK 500 GLN B1777 48.42 96.74 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1632 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 511 OD2 REMARK 620 2 HIS A 513 ND1 115.5 REMARK 620 3 HIS A 515 ND1 112.0 116.1 REMARK 620 4 HIS B1809 NE2 102.0 103.5 105.8 REMARK 620 N 1 2 3
REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED.
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A1632 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EPE B2858
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1H4U RELATED DB: PDB REMARK 900 DOMAIN G2 OF MOUSE NIDOGEN-1
DBREF 1GL4 A 353 356 PDB 1GL4 1GL4 353 356 DBREF 1GL4 A 357 637 UNP P10493 NIDO_MOUSE 385 665 DBREF 1GL4 B 1761 1764 PDB 1GL4 1GL4 1761 1764 DBREF 1GL4 B 1765 1858 UNP Q05793 PGBM_MOUSE 1765 1858
SEQRES 1 A 285 ALA PRO LEU ALA GLN GLN THR CYS ALA ASN ASN ARG HIS SEQRES 2 A 285 GLN CYS SER VAL HIS ALA GLU CYS ARG ASP TYR ALA THR SEQRES 3 A 285 GLY PHE CYS CYS ARG CYS VAL ALA ASN TYR THR GLY ASN SEQRES 4 A 285 GLY ARG GLN CYS VAL ALA GLU GLY SER PRO GLN ARG VAL SEQRES 5 A 285 ASN GLY LYS VAL LYS GLY ARG ILE PHE VAL GLY SER SER SEQRES 6 A 285 GLN VAL PRO VAL VAL PHE GLU ASN THR ASP LEU HIS SER SEQRES 7 A 285 TYR VAL VAL MET ASN HIS GLY ARG SER TYR THR ALA ILE SEQRES 8 A 285 SER THR ILE PRO GLU THR VAL GLY TYR SER LEU LEU PRO SEQRES 9 A 285 LEU ALA PRO ILE GLY GLY ILE ILE GLY TRP MET PHE ALA SEQRES 10 A 285 VAL GLU GLN ASP GLY PHE LYS ASN GLY PHE SER ILE THR SEQRES 11 A 285 GLY GLY GLU PHE THR ARG GLN ALA GLU VAL THR PHE LEU SEQRES 12 A 285 GLY HIS PRO GLY LYS LEU VAL LEU LYS GLN GLN PHE SER SEQRES 13 A 285 GLY ILE ASP GLU HIS GLY HIS LEU THR ILE SER THR GLU SEQRES 14 A 285 LEU GLU GLY ARG VAL PRO GLN ILE PRO TYR GLY ALA SER SEQRES 15 A 285 VAL HIS ILE GLU PRO TYR THR GLU LEU TYR HIS TYR SER SEQRES 16 A 285 SER SER VAL ILE THR SER SER SER THR ARG GLU TYR THR SEQRES 17 A 285 VAL MET GLU PRO ASP GLN ASP GLY ALA ALA PRO SER HIS SEQRES 18 A 285 THR HIS ILE TYR GLN TRP ARG GLN THR ILE THR PHE GLN SEQRES 19 A 285 GLU CYS ALA HIS ASP ASP ALA ARG PRO ALA LEU PRO SER SEQRES 20 A 285 THR GLN GLN LEU SER VAL ASP SER VAL PHE VAL LEU TYR SEQRES 21 A 285 ASN LYS GLU GLU ARG ILE LEU ARG TYR ALA LEU SER ASN SEQRES 22 A 285 SER ILE GLY PRO VAL ARG ASP GLY SER PRO ASP ALA SEQRES 1 B 98 ALA PRO LEU ALA ALA PRO SER LYS PRO ILE MET VAL THR SEQRES 2 B 98 VAL GLU GLU GLN ARG SER GLN SER VAL ARG PRO GLY ALA SEQRES 3 B 98 ASP VAL THR PHE ILE CYS THR ALA LYS SER LYS SER PRO SEQRES 4 B 98 ALA TYR THR LEU VAL TRP THR ARG LEU HIS ASN GLY LYS SEQRES 5 B 98 LEU PRO SER ARG ALA MET ASP PHE ASN GLY ILE LEU THR SEQRES 6 B 98 ILE ARG ASN VAL GLN PRO SER ASP ALA GLY THR TYR VAL SEQRES 7 B 98 CYS THR GLY SER ASN MET PHE ALA MET ASP GLN GLY THR SEQRES 8 B 98 ALA THR LEU HIS VAL GLN VAL
HET ZN A1632 1 HET EPE B2858 15
HETNAM ZN ZINC ION HETNAM EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE HETNAM 2 EPE ETHANESULFONIC ACID
FORMUL 3 ZN ZN 2+ FORMUL 4 EPE C8 H18 N2 O4 S FORMUL 5 HOH *174(H2 O1)
HELIX 1 1 THR A 359 ARG A 364 1 6 HELIX 2 2 HIS A 365 CYS A 367 5 3 HELIX 3 3 PRO A 447 TYR A 452 1 6 HELIX 4 4 SER A 453 LEU A 455 5 3 HELIX 5 5 ALA A 458 PHE A 468 1 11 HELIX 6 6 ASN A 477 GLY A 483 1 7 HELIX 7 7 GLN B 1830 ALA B 1834 5 5
SHEET 1 AA 2 ALA A 371 ASP A 375 0 SHEET 2 AA 2 PHE A 380 CYS A 384 -1 O CYS A 381 N ARG A 374 SHEET 1 AB 2 TYR A 388 GLY A 390 0 SHEET 2 AB 2 CYS A 395 ALA A 397 -1 O VAL A 396 N THR A 389 SHEET 1 AC 5 VAL A 470 GLU A 471 0 SHEET 2 AC 5 ILE A 618 GLY A 628 1 O ASN A 625 N VAL A 470 SHEET 3 AC 5 ARG A 438 SER A 444 -1 O SER A 439 N LEU A 623 SHEET 4 AC 5 VAL A 421 VAL A 433 -1 O ASP A 427 N SER A 444 SHEET 5 AC 5 PRO A 401 VAL A 414 -1 O GLN A 402 N VAL A 432 SHEET 1 AD 5 VAL A 470 GLU A 471 0 SHEET 2 AD 5 ILE A 618 GLY A 628 1 O ASN A 625 N VAL A 470 SHEET 3 AD 5 THR A 600 ASN A 613 -1 O GLN A 602 N GLY A 628 SHEET 4 AD 5 TYR A 540 SER A 547 -1 O TYR A 540 N VAL A 605 SHEET 5 AD 5 VAL A 550 MET A 562 -1 O VAL A 550 N SER A 547 SHEET 1 BA 4 ILE B1770 VAL B1774 0 SHEET 2 BA 4 VAL B1788 SER B1796 -1 O THR B1793 N THR B1773 SHEET 3 BA 4 ILE B1823 ILE B1826 -1 O LEU B1824 N PHE B1790 SHEET 4 BA 4 ALA B1817 PHE B1820 -1 O MET B1818 N THR B1825 SHEET 1 BB 4 SER B1779 VAL B1782 0 SHEET 2 BB 4 MET B1847 VAL B1856 1 O THR B1853 N GLN B1780 SHEET 3 BB 4 GLY B1835 SER B1842 -1 O GLY B1835 N LEU B1854 SHEET 4 BB 4 THR B1802 ARG B1807 -1 O THR B1802 N SER B1842
SSBOND 1 CYS A 360 CYS A 373 1555 1555 2.04 SSBOND 2 CYS A 367 CYS A 382 1555 1555 2.03 SSBOND 3 CYS A 381 CYS A 588 1555 1555 2.03 SSBOND 4 CYS A 384 CYS A 395 1555 1555 2.03 SSBOND 5 CYS B 1792 CYS B 1839 1555 1555 2.03
LINK ZN ZN A1632 OD2 ASP A 511 1555 1555 2.10 LINK ZN ZN A1632 ND1 HIS A 513 1555 1555 2.15 LINK ZN ZN A1632 ND1 HIS A 515 1555 1555 2.66 LINK ZN ZN A1632 NE2 HIS B1809 1555 4556 2.17
SITE 1 AC1 4 ASP A 511 HIS A 513 HIS A 515 HIS B1809 SITE 1 AC2 5 LEU B1808 HIS B1809 GLN B1849 THR B1851 SITE 2 AC2 5 HOH B2023
CRYST1 55.920 72.300 103.930 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.017883 0.000000 0.000000 0.00000
SCALE2 0.000000 0.013831 0.000000 0.00000
SCALE3 0.000000 0.000000 0.009622 0.00000